NO20004679D0 - Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse - Google Patents
Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelseInfo
- Publication number
- NO20004679D0 NO20004679D0 NO20004679A NO20004679A NO20004679D0 NO 20004679 D0 NO20004679 D0 NO 20004679D0 NO 20004679 A NO20004679 A NO 20004679A NO 20004679 A NO20004679 A NO 20004679A NO 20004679 D0 NO20004679 D0 NO 20004679D0
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- prevention
- pharmaceutical composition
- composition containing
- protease inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7228098 | 1998-03-20 | ||
| PCT/JP1999/001335 WO1999048522A1 (en) | 1998-03-20 | 1999-03-17 | Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004679D0 true NO20004679D0 (no) | 2000-09-19 |
| NO20004679L NO20004679L (no) | 2000-10-26 |
Family
ID=13484725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004679A NO20004679L (no) | 1998-03-20 | 2000-09-19 | Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6342531B1 (no) |
| EP (1) | EP1064021B1 (no) |
| JP (1) | JP2002507579A (no) |
| KR (1) | KR20010041967A (no) |
| CN (1) | CN1301173A (no) |
| AR (1) | AR018784A1 (no) |
| AT (1) | ATE275420T1 (no) |
| AU (1) | AU2852699A (no) |
| BR (1) | BR9908948A (no) |
| CA (1) | CA2324566A1 (no) |
| DE (1) | DE69919995T2 (no) |
| ES (1) | ES2224613T3 (no) |
| HU (1) | HUP0101428A2 (no) |
| ID (1) | ID27507A (no) |
| MX (1) | MXPA00009188A (no) |
| MY (1) | MY133063A (no) |
| NO (1) | NO20004679L (no) |
| PL (1) | PL342970A1 (no) |
| WO (1) | WO1999048522A1 (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7766300A (en) * | 1999-10-07 | 2001-05-10 | Novaneuron Inc. | Gene necessary for striatal function, uses thereof, and compounds for modulatingsame |
| AU2001292287A1 (en) | 2000-10-26 | 2002-05-06 | Senju Pharmaceutical Co. Ltd. | Drug composition comprising dipeptydyl aldehyde derivative |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0564552A1 (en) | 1990-12-28 | 1993-10-13 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| DE69628050T2 (de) | 1995-10-25 | 2004-04-01 | Senju Pharmaceutical Co., Ltd. | Angiogenese Hemmer |
-
1999
- 1999-03-17 EP EP99909212A patent/EP1064021B1/en not_active Expired - Lifetime
- 1999-03-17 CA CA002324566A patent/CA2324566A1/en not_active Abandoned
- 1999-03-17 JP JP2000537569A patent/JP2002507579A/ja not_active Ceased
- 1999-03-17 CN CN99806167A patent/CN1301173A/zh active Pending
- 1999-03-17 ES ES99909212T patent/ES2224613T3/es not_active Expired - Lifetime
- 1999-03-17 DE DE69919995T patent/DE69919995T2/de not_active Expired - Lifetime
- 1999-03-17 AT AT99909212T patent/ATE275420T1/de not_active IP Right Cessation
- 1999-03-17 MX MXPA00009188A patent/MXPA00009188A/es unknown
- 1999-03-17 MY MYPI99000998A patent/MY133063A/en unknown
- 1999-03-17 HU HU0101428A patent/HUP0101428A2/hu unknown
- 1999-03-17 PL PL99342970A patent/PL342970A1/xx not_active Application Discontinuation
- 1999-03-17 AU AU28526/99A patent/AU2852699A/en not_active Abandoned
- 1999-03-17 BR BR9908948-3A patent/BR9908948A/pt not_active Application Discontinuation
- 1999-03-17 KR KR1020007010291A patent/KR20010041967A/ko not_active Application Discontinuation
- 1999-03-17 US US09/646,529 patent/US6342531B1/en not_active Expired - Fee Related
- 1999-03-17 WO PCT/JP1999/001335 patent/WO1999048522A1/en active IP Right Grant
- 1999-03-17 ID IDW20002104A patent/ID27507A/id unknown
- 1999-03-19 AR ARP990101215A patent/AR018784A1/es unknown
-
2000
- 2000-09-19 NO NO20004679A patent/NO20004679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999048522A1 (en) | 1999-09-30 |
| DE69919995T2 (de) | 2005-09-22 |
| ATE275420T1 (de) | 2004-09-15 |
| ES2224613T3 (es) | 2005-03-01 |
| DE69919995D1 (de) | 2004-10-14 |
| MY133063A (en) | 2007-10-31 |
| NO20004679L (no) | 2000-10-26 |
| EP1064021A1 (en) | 2001-01-03 |
| CN1301173A (zh) | 2001-06-27 |
| KR20010041967A (ko) | 2001-05-25 |
| PL342970A1 (en) | 2001-07-16 |
| CA2324566A1 (en) | 1999-09-30 |
| BR9908948A (pt) | 2000-11-21 |
| JP2002507579A (ja) | 2002-03-12 |
| ID27507A (id) | 2001-04-12 |
| HUP0101428A2 (hu) | 2001-09-28 |
| US6342531B1 (en) | 2002-01-29 |
| AU2852699A (en) | 1999-10-18 |
| MXPA00009188A (es) | 2002-04-24 |
| EP1064021B1 (en) | 2004-09-08 |
| AR018784A1 (es) | 2001-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0400206A3 (en) | Imidazolidindion derivatives having metalloproteinase inhibitor effect a their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP9900964A3 (en) | Protease inhibitors and pharmaceutical compositions containing these compounds | |
| NO990548D0 (no) | Inhibitorer for cystein-protease | |
| IL165255A0 (en) | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for teh treatment of alzheimer's disease | |
| HU9303218D0 (en) | Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia | |
| ID30062A (id) | Alanog-analog benzopiran tersubstitusi untuk pengobatan radang | |
| HUP0105077A3 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
| HUP0303083A3 (en) | Pharmaceutical compositions containing therapeutic combination of a cetp inhibitor and atorvastatin and their use | |
| HUP0000210A3 (en) | Heterocyclic compounds as metalloprotease inhibitors and use of them for producing pharmaceutical compisitions | |
| ZA986208B (en) | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| HUP0103806A3 (en) | Serine protease inhibitor and pharmaceutical compositions containing them | |
| AU5329096A (en) | Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases | |
| EP1196162A4 (en) | OLIGOMERS OF PROCYANIDINE INHIBITORS OF MATRIX METALLOPROTEASES AND MEDICAMENTS USING THEM AS ACTIVE INGREDIENT | |
| EP0923535A4 (en) | CYSTEINE PROTEASE INHIBITORS | |
| IS4805A (is) | Aðferð til meðhöndlunar og lyfjasamsetning | |
| IL120311A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
| HUP0401582A3 (en) | Pharmaceutical compositions containing combination of nsaid and pde-4 inhibitors and their use | |
| IL120310A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
| NO983926L (no) | Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer | |
| IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| HUP0101224A3 (en) | Pyrrolidine derivatives as inhibitors of neuraminidases and pharmaceutical compositions containing them | |
| NO20004679D0 (no) | Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse | |
| IL112423A0 (en) | Inhibitors of serine proteases, their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |